Glirid 1 mg (Tablet)
Unit Price: ৳ 6.00 (3 x 10: ৳ 180.00)
Strip Price: ৳ 60.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Glimepiride |
| Company | General pharmaceuticals ltd |
| Also available as |
Title
- Glirid Tablet
Categories
- Medicine
- Diabetes Care
- Oral Antidiabetic
Description
- Glirid is an oral antidiabetic medication used to lower blood glucose levels in patients with noninsulin dependent (Type II) diabetes mellitus (NIDDM) whose hyperglycaemia cannot be controlled by diet and exercise alone.
Dimensions
N/A
Color Options
N/A
Functions
- Lowers blood glucose levels
- Stimulates the release of insulin from pancreatic beta cells
- Reduces basal hepatic glucose production
- Increases peripheral tissue sensitivity to insulin and glucose uptake
Materials
N/A
Technical Specifications
- Hypoglycaemic action persists for 24 hours
- Dosage is based on desired blood sugar level and regular glucose monitoring
- Tablet must be swallowed with sufficient amount of liquid
Design Elements
N/A
Usability Features
- Initial dose is 1 mg once daily, can be increased gradually based on blood sugar monitoring
- Single daily dose, preferably taken before breakfast or first main meal
- Consideration for dose adjustment with changes in weight or lifestyle
Interactions
- Potentiates hypoglycaemic action with ACE inhibitors, aminosalicylic acid, and others
- Attenuates hypoglycaemic action with acetazolamide, corticosteroids, and others
- May be masked by beta-blockers, clonidine, or reserpine
- Effects may be altered by alcohol intake
Contraindications
- Not suitable for insulin dependent (type I) diabetes mellitus
- Not for use in diabetic ketoacidosis or diabetic coma
- Contraindicated in patients hypersensitive to Glimepiride
- Not for severe hepatic dysfunction, severe impairment of renal function, and dialysis patients
Side Effects
- Hypoglycaemia
- Temporary visual impairment
- Nausea
- Vomiting
- Diarrhoea
- Abdominal pain
- Urticaria
- Fall in blood pressure
Pregnancy & Lactation
- Must not be taken during pregnancy; changeover to insulin necessary
- Harmful if taken by breastfeeding women; changeover or discontinuation of breastfeeding necessary
Precautions & Warnings
- Initial weeks of treatment may increase risk of hypoglycaemia
- Necessitates careful monitoring
- Hypoglycaemia can be controlled by immediate intake of carbohydrates
Overdose Effects
- Can produce hypoglycaemia
- Mild symptoms treated with oral glucose and adjustments in drug dosage or meal patterns
- Severe reactions require immediate hospitalization
Therapeutic Class
- Sulfonylureas
Storage Conditions
- Do not store above 30°C
- Keep away from light and out of the reach of children